SOURCE: Antisoma plc

September 03, 2009 07:07 ET

Antisoma to present at the Rodman & Renshaw Healthcare Conference in New York

LONDON--(Marketwire - September 3, 2009) -

3 September 2009, London, UK, and Cambridge, MA: Antisoma plc (LSE: ASM; USOTC: ATSMY) announces that Daniel Elger, VP Marketing & Communications, will present an overview of the Company's strategy, programmes and prospects at the Rodman & Renshaw 11th Annual Healthcare Conference in New York City, on Thursday, September 10th at 09:10 EDT/14:10 BST.

A webcast of the presentation will be available on Antisoma's website at

For live viewing of the webcast, it is recommended that viewers log on 15 minutes early in order to register and download any necessary software.

Chris Elston
Marketing and Communications Manager
Antisoma plc
+44 (0)20 3249 2100

Background on Antisoma

Antisoma is a London Stock Exchange-listed biopharmaceutical company that develops novel products for the treatment of cancer. The Company has operations in the UK and the US. Please visit for further information about Antisoma.


This announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.

Copyright © Hugin AS 2009. All rights reserved.

Contact Information